Accessibility Accessibility icon
CONSULTATION (303) 951-5829
Accent Image
How can I improve the results of my BOTOX treatment?

How can I improve the results of my BOTOX treatment?

How can I improve the results of my BOTOX treatment?

October 27, 2015

At BEAUTY by BUFORD, we are always looking for ways to improve our results. Our patients are discerning and they are educated and they simply won’t accept a fairly good result. They want us to continually improve on our treatments and to look for ways to provide even greater and more long lasting benefits.

Introducing ThermiTox.

The revolutionary new ThermiTox procedure combines the proven results of BOTOX Cosmetic with the power of ThermiSmooth radiofrequency (RF) skin tightening and smoothing. Your first treatment will take no more than 45 minutes and will begin with ThermiSmooth to the skin around your eyes followed by gentle administration of BOTOX Cosmetic. From there, we suggest an addition 2 more ThermiSmooth treatments to the same area each spaced 2-3 weeks apart. Treatments are associated with ZERO downtime; we just ask that you not exercise or rub the treated areas for 6 hours following your initial treatment.

The combination of BOTOX Cosmetic and ThermiSmooth simply makes sense. Your treatment begins with a painless ThermiSmooth treatment, which heats the skin to encourage collagen remodeling and improvement of wrinkles. This is then followed by administration of BOTOX Cosmetic to help this skin in these treated areas tighten and rejuvenate under less tension so that maximum improvement can be achieved.

Standard pricing for this combination procedure will be:  $500

  • BOTOX Cosmetic (20 units)
  • ThermiSmooth (3 treatments)

To introduce you to this amazing procedure, we are offering incentives on the ThermiTox procedure throughout the month of November. To learn more, please call us at 303.747.6719 or email us at Jen@beautybybuford.com

Thanks again for your continued support! We look forward to working with you.

Visualize your NEW LOOK in 3D NOW

START NOW
Natrelle® Breast Implants
IMPORTANT SAFETY INFORMATION

Breast implants are not lifetime devices. The longer patients have them, the greater the chance they will develop complications, which may require more surgery. Breast implants have been associated with a cancer of the immune system called breast implant–associated anaplastic large cell lymphoma (BIA-ALCL). Some patients have died from BIA-ALCL. Patients have also reported a variety of systemic symptoms such as joint pain, muscle aches, confusion, chronic fatigue, autoimmune diseases, and others.

Natrelle® Breast Implants are for breast augmentation and revision surgery in women at least 22 years old for silicone-filled implants and women at least 18 years old for saline-filled implants.

You should not get breast implants if you currently have an active infection, untreated breast cancer or precancer, or are pregnant or nursing. Tell your doctor about any conditions you have, any medications you are taking, and any planned cancer treatments. Breast implantation is likely not a one-time surgery.

Having implants removed and not replaced may lead to permanent cosmetic changes of the breasts. Breast implants may affect breastfeeding. Gel implants may rupture without symptoms, so periodic imaging after surgery is recommended.

Key complications are reoperation, implant removal, implant rupture, implant deflation with saline-filled implants, and severe capsular contracture.

Talk to your doctor for more information.

The use of Natrelle® Breast Implants is restricted to licensed physicians who provide information to patients about the risks and benefits of breast implant surgery.

Visualize your
NEW LOOK in 3D NOW!

Start now
START NOW
Natrelle® Breast Implants
IMPORTANT SAFETY INFORMATION

Breast implants are not lifetime devices. The longer patients have them, the greater the chance they will develop complications, which may require more surgery. Breast implants have been associated with a cancer of the immune system called breast implant–associated anaplastic large cell lymphoma (BIA-ALCL). Some patients have died from BIA-ALCL. Patients have also reported a variety of systemic symptoms such as joint pain, muscle aches, confusion, chronic fatigue, autoimmune diseases, and others.

Breast implants are not lifetime devices. The longer patients have them, the greater the chance they will develop complications, which may require more surgery. Breast implants have been associated with a cancer of the immune system called breast implant–associated anaplastic large cell lymphoma (BIA-ALCL). Some patients have died from BIA-ALCL. Patients have also reported a variety of systemic symptoms such as joint pain, muscle aches, confusion, chronic fatigue, autoimmune diseases, and others.

Breast implants are not lifetime devices. The longer patients have them, the greater the chance they will develop complications, which may require more surgery. Breast implants have been associated with a cancer of the immune system called breast implant–associated anaplastic large cell lymphoma (BIA-ALCL). Some patients have died from BIA-ALCL. Patients have also reported a variety of systemic symptoms such as joint pain, muscle aches, confusion, chronic fatigue, autoimmune diseases, and others.

Breast implants are not lifetime devices. The longer patients have them, the greater the chance they will develop complications, which may require more surgery. Breast implants have been associated with a cancer of the immune system called breast implant–associated anaplastic large cell lymphoma (BIA-ALCL). Some patients have died from BIA-ALCL. Patients have also reported a variety of systemic symptoms such as joint pain, muscle aches, confusion, chronic fatigue, autoimmune diseases, and others.